Literature DB >> 9512484

Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function?

I C Gelissen1, T Hochgrebe, M R Wilson, S B Easterbrook-Smith, W Jessup, R T Dean, A J Brown.   

Abstract

Apolipoprotein J (apo J) is a secreted glycoprotein of which the exact function remains a matter for speculation. Apo J has been implicated in such diverse processes as sperm maturation, regulation of complement activation, programmed cell death, tissue remodelling and lipid transport. In this study a possible role for apo J in lipid transport was explored. Mouse peritoneal macrophages were incubated with acetylated low-density lipoprotein (AcLDL) to produce foam cells containing cholesterol and cholesteryl esters. Incubation of the foam cells with physiological concentrations of purified apo J led to a dose-dependent export of cholesterol. The appearance of cholesterol in the medium was associated predominantly with a decline in intracellular cholesteryl esters rather than intracellular free cholesterol. The kinetics of cholesterol release to apo J were similar to apo A-I, an established promoter of cholesterol efflux. Apo J was also shown to induce phospholipid efflux from cells, whereas the cholesterol exported to the medium was associated with the apo J. Studies using foam cells from apo E-null mice showed that the cholesterol exported to the medium was independent of apo E production by the cells. These results present the first evidence that apo J can promote cholesterol efflux from foam cells and indicates that it might have a function in cellular cholesterol homoeostasis in both normal and pathological situations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512484      PMCID: PMC1219343          DOI: 10.1042/bj3310231

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Relative topography of biologically active domains of human vitronectin. Evidence from monoclonal antibody epitope and denaturation studies.

Authors:  C A Morris; P A Underwood; P A Bean; M Sheehan; J A Charlesworth
Journal:  J Biol Chem       Date:  1994-09-23       Impact factor: 5.157

3.  Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes.

Authors:  S K Basu; Y K Ho; M S Brown; D W Bilheimer; R G Anderson; J L Goldstein
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

4.  Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT.

Authors:  T M Forte; J K Bielicki; R Goth-Goldstein; J Selmek; M R McCall
Journal:  J Lipid Res       Date:  1995-01       Impact factor: 5.922

5.  Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis.

Authors:  T C Jordan-Starck; S D Lund; D P Witte; B J Aronow; C A Ley; W D Stuart; D K Swertfeger; L R Clayton; S F Sells; B Paigen
Journal:  J Lipid Res       Date:  1994-02       Impact factor: 5.922

6.  A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC.

Authors:  L Kritharides; W Jessup; J Gifford; R T Dean
Journal:  Anal Biochem       Date:  1993-08-15       Impact factor: 3.365

7.  Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.

Authors:  J Tschopp; A Chonn; S Hertig; L E French
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

8.  Sterol to phospholipid molar ratios of L cells with qualitative and quantitative variations of cellular sterol.

Authors:  L Sokoloff; G H Rothblat
Journal:  Proc Soc Exp Biol Med       Date:  1974-09

9.  Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents.

Authors:  Y K Ho; M S Brown; J L Goldstein
Journal:  J Lipid Res       Date:  1980-05       Impact factor: 5.922

10.  Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophages.

Authors:  L Kritharides; W Jessup; E L Mander; R T Dean
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-02       Impact factor: 8.311

View more
  34 in total

Review 1.  Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease.

Authors:  W G Wood; F Schroeder; N A Avdulov; S V Chochina; U Igbavboa
Journal:  Lipids       Date:  1999-03       Impact factor: 1.880

Review 2.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 3.  The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.

Authors:  Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-01-25       Impact factor: 5.590

4.  Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans.

Authors:  Allison B Andraski; Sasha A Singh; Lang Ho Lee; Hideyuki Higashi; Nathaniel Smith; Bo Zhang; Masanori Aikawa; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-26       Impact factor: 8.311

5.  Effects of human follicular fluid and high-density lipoproteins on early spermatozoa hyperactivation and cholesterol efflux.

Authors:  Safouane M Hamdi; Gérard Vieitez; Béatrice Jaspard; Ronald Barbaras; Bertrand Perret; Roget Mieusset; Jean Parinaud; Xavier Collet
Journal:  J Lipid Res       Date:  2009-11-30       Impact factor: 5.922

6.  Nerve growth factor and epidermal growth factor stimulate clusterin gene expression in PC12 cells.

Authors:  C Gutacker; G Klock; P Diel; C Koch-Brandt
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

Review 7.  Dyslipidemia and the risk of Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

8.  Combined statin and niacin therapy remodels the high-density lipoprotein proteome.

Authors:  Pattie S Green; Tomas Vaisar; Subramaniam Pennathur; J Jacob Kulstad; Andrew B Moore; Santica Marcovina; John Brunzell; Robert H Knopp; Xue-Qiao Zhao; Jay W Heinecke
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

9.  Diabetic dyslipidemia and exercise alter the plasma low-density lipoproteome in Yucatan pigs.

Authors:  Matthew R Richardson; Xianyin Lai; Joseph L Dixon; Michael Sturek; Frank A Witzmann
Journal:  Proteomics       Date:  2009-05       Impact factor: 3.984

10.  EFFECT OF SELENIUM SUPPLEMENTATION ON PROTEOMIC SERUM BIOMARKERS IN ELDERLY MEN.

Authors:  A M Algotar; R Behnejad; P Singh; P A Thompson; C H Hsu; S P Stratton
Journal:  J Frailty Aging       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.